Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of IVIEW-1201 In The Treatment Of Acute Adenoviral Conjunctivitis

NCT03749317 is registered in ClinicalTrials.gov with IVIEW Therapeutics Inc. as lead sponsor.

NCT NCT03749317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03749317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of IVIEW-1201 In The Treatment Of Acute Adenoviral Conjunctivitis
Lead sponsor
IVIEW Therapeutics Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 20, 2023
Completion date
December 31, 2024
Enrollment
135 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenoviral conjunctivitis